Mutual Recognition Procedure

The Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) last week explained how regulatory flexibilities for medicines amid the coronavirus disease (COVID-19) ...

Mutual Recognition Procedure 1

Despite earlier recommendations to the contrary, as of 1 January 2018 all types of EU mutual recognition procedure (“MRP”) submissions should be made in electronic Common Technical Document format ...

Business Wire: Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorisation of BioThrax in European Countries

GAITHERSBURG, Md, USA--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorisation of BioThrax ® ...

Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorisation of BioThrax in European Countries

Business Insider: DGAP-News: Biotest AG: Biotest AG announces successful completion of Mutual Recognition Procedure for marketing authorization of Cytotect(R) CP Biotest in twelve European countries

Mutual Recognition Procedure 6

Biotest AG: Biotest AG announces successful completion of Mutual Recognition Procedure for marketing authorization of Cytotect(R) CP Biotest in twelve European countries 21.08.2018 / 07:00 The issuer ...

DGAP-News: Biotest AG: Biotest AG announces successful completion of Mutual Recognition Procedure for marketing authorization of Cytotect(R) CP Biotest in twelve European countries

JD Supra: UK’s Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024

Earlier this year, the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), announced that a new International Recognition Procedure (IRP) will be put in place for ...

UK’s Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024

Mutual Recognition Procedure 11